Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,446 total articles

SL Science Announces Successful Exhibition of Breakthrough Brain Cancer Therapy Research at the 2026 World Congress of Basic and Clinical Pharmacology

SL Science Announces Successful Exhibition of Breakthrough Brain Cancer Therapy Research at the 2026 World Congress of Basic and Clinical Pharmacology

SL Science Holding Limited announced successful presentation of preclinical data demonstrating the potent anti-glioblastoma effects of their novel gamma delta T-cell therapy at the 2026 World Congress of Basic and Clinical Pharmacology. The research, conducted in collaboration with Taipei Medical University, JY BioMed, and HeXun Biosciences, showed…

Nano Dimension Continues Execution of Cost Savings Initiatives

Nano Dimension Continues Execution of Cost Savings Initiatives

Nano Dimension Ltd. announced the termination of its corporate headquarters lease, originally set to expire in 2031, resulting in approximately $25 million net cash savings after lease termination payment. This move is part of broader cost-saving initiatives following the sale of MarkForged, aiming to strengthen the company's financial position by …

General Fusion to Ring Nasdaq Opening Bell Today, July 17, 2026

General Fusion to Ring Nasdaq Opening Bell Today, July 17, 2026

General Fusion Group Ltd. announced its recent listing on Nasdaq under the ticker GFUZ and its celebration ringing the Nasdaq Opening Bell, marking it as the first publicly listed fusion energy company. The company highlighted its Magnetized Target Fusion (MTF) technology and the development of its LM26 fusion demonstration machine, aiming to achie…

NANO Nuclear Energy Joins Virginia Nuclear Energy Consortium to Advance Nuclear Innovation and Support the Commonwealth’s Growing Energy Requirements

NANO Nuclear Energy Joins Virginia Nuclear Energy Consortium to Advance Nuclear Innovation and Support the Commonwealth’s Growing Energy Requirements

NANO Nuclear Energy Inc. (NASDAQ: NNE) has joined the Virginia Nuclear Energy Consortium (VNEC) to collaborate on advancing nuclear energy innovation, deployment, research, and workforce initiatives in Virginia, a state experiencing rapid growth in power demand, especially from data centers. As a part of VNEC, NANO Nuclear aims to leverage Virginia…

Abacus Global Management to Announce Second Quarter 2026 Financial Results on Thursday, August 6, 2026

Abacus Global Management to Announce Second Quarter 2026 Financial Results on Thursday, August 6, 2026

Abacus Global Management, a NYSE-listed financial services firm specializing in alternative asset management, announced it will release its Q2 2026 financial results after market close on August 6, 2026. The company will host a conference call and webcast to discuss the results the same day, providing investors with an opportunity to engage and ass…

Damora Announces Redomestication from Delaware to Cayman Islands

Damora Announces Redomestication from Delaware to Cayman Islands

Damora Therapeutics, a biotechnology company focused on treatments for blood disorders, announced its redomestication from Delaware to the Cayman Islands effective July 16, 2026. The company's shares will continue to trade on Nasdaq under the symbol DMRA with a new CUSIP. The redomestication does not change the company's operations or management.

Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations

Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations

Amneal Pharmaceuticals has obtained FDA approval for new strengths and vial sizes of its iohexol injection, a radiographic contrast agent used in various imaging procedures. The expanded portfolio is set to meet most of the U.S. iohexol injection market demand, positioning Amneal as a key player in complex injectables and hospital products. The com…

VisionWave Files Provisional Patent Application for GhostSight™, a Hybrid Passive Radar Architecture Using Intelligent Cooperative Illumination

VisionWave Files Provisional Patent Application for GhostSight™, a Hybrid Passive Radar Architecture Using Intelligent Cooperative Illumination

VisionWave Holdings announces filing of a provisional patent application for GhostSight™, a hybrid passive radar system that combines environmental RF signals with distributed cooperative illuminators, enhanced by AI/ML fusion for improved detection, classification, and situational awareness across defense and security sectors.

Wakefern and ShopRite Expand Edible Garden’s Successful “Garden Starters” Program with Midsummer Promotion

Wakefern and ShopRite Expand Edible Garden’s Successful “Garden Starters” Program with Midsummer Promotion

Edible Garden AG Incorporated announced that Wakefern Food Corp. is expanding the Garden Starters pallet display program with a midsummer promotional event at participating ShopRite locations. The program features USDA Organic Certified living herb plants to meet rising consumer demand for fresh, sustainable produce and promote home gardening. Edib…

Clearmind Medicine Commends Federal Momentum in Advancing Psychedelic-Based Therapies for Mental Health and Addiction

Clearmind Medicine Commends Federal Momentum in Advancing Psychedelic-Based Therapies for Mental Health and Addiction

Clearmind Medicine Inc., trading as CMND on Nasdaq, applauds recent developments by multiple U.S. federal agencies including FDA, HHS, VA and others, which support the advancement of psychedelic-based therapies for neuropsychiatric and addiction disorders. The company highlights regulatory progress such as final FDA guidance on psychedelic clinical…

Evaxion to present three-year clinical efficacy data for personalized cancer vaccine EVX-01 at the ESMO Congress 2026

Evaxion to present three-year clinical efficacy data for personalized cancer vaccine EVX-01 at the ESMO Congress 2026

Evaxion A/S will present three-year clinical efficacy data from its phase 2 trial of personalized cancer vaccine EVX-01 at the upcoming ESMO Congress 2026. The data includes insights on EVX-01's durability and effectiveness as a stand-alone treatment for advanced melanoma. Previous two-year results showed high response rates and sustained immune re…

AmpliTech Group Approved for Membership in the AI-RAN Alliance, the Global Consortium Founded by Leading Technology Companies to Bring Artificial Intelligence to Wireless Networks

AmpliTech Group Approved for Membership in the AI-RAN Alliance, the Global Consortium Founded by Leading Technology Companies to Bring Artificial Intelligence to Wireless Networks

AmpliTech Group, Inc., a US-based developer of advanced RF and 5G systems, announced its membership in the AI-RAN Alliance, a global consortium focused on embedding AI into radio access network technology. This move aligns AmpliTech with industry leaders to drive innovation in AI-powered wireless infrastructure amid a rapidly growing AI-RAN market …

Balchem Corporation Announces Quarterly Conference Call for Second Quarter 2026 Financial Results on July 31, 2026

Balchem Corporation Announces Quarterly Conference Call for Second Quarter 2026 Financial Results on July 31, 2026

Balchem Corporation announced its second quarter 2026 financial results will be released before market open on July 31, 2026, followed by a conference call hosted by CEO Ted Harris and CFO Martin Bengtsson. The company provides specialty ingredients for human and animal nutrition as well as specialty products across various industries.

Kalaris Therapeutics Reports Positive TH103 Phase 1a SAD Results from Expanded Neovascular AMD Cohorts

Kalaris Therapeutics Reports Positive TH103 Phase 1a SAD Results from Expanded Neovascular AMD Cohorts

Kalaris Therapeutics reported positive results from its Phase 1a single ascending dose trial of TH103 for neovascular age-related macular degeneration (AMD). The expanded cohort data showed robust improvements in vision and retinal anatomy, with prolonged biological activity and reduced need for re-treatment. No significant adverse inflammation was…

Click Holdings Limited (CLIK) Surpasses 6 Million Senior Care Hours; Unveils Global ESG Framework to Power International and Mainland China Expansion

Click Holdings Limited (CLIK) Surpasses 6 Million Senior Care Hours; Unveils Global ESG Framework to Power International and Mainland China Expansion

Click Holdings Limited (NASDAQ: CLIK), a Hong Kong-based leader in AI-powered human resources and senior care solutions, has delivered over 6 million senior care hours, marking a milestone in its growth and social impact. The company reports strong financial results with a 73% year-over-year revenue increase and a strategic expansion plan targeting…

BrewDog and Tilray Brands Unlock £1 Million Bar Tab for Football Fans Across England, Scotland and Ireland

BrewDog and Tilray Brands Unlock £1 Million Bar Tab for Football Fans Across England, Scotland and Ireland

Tilray Brands, through its ownership of BrewDog, is launching a £1 million bar tab across its BrewDog pubs in Scotland, England, and Ireland. The initiative aims to unite football fans by offering two free pints per person via the BrewDog Treats loyalty platform between July 20 and September 30, 2026. This campaign will coincide with major sports e…